321
Participants
Start Date
September 10, 2018
Primary Completion Date
September 14, 2022
Study Completion Date
October 19, 2022
AZR-MD-001 Low Dose
AZR-MD-001 is an ophthalmic ointment
AZR-MD-001 Mid Dose
AZR-MD-001 is an ophthalmic ointment
AZR-MD-001 High Dose
AZR-MD-001 is an ophthalmic ointment
AZR-MD-001 Vehicle
AZR-MD-001 is a vehicle ophthalmic ointment
University of Auckland, Auckland
AucklandEye, Auckland
Eye Associates, Sydney
Sydney Eye Hospital, Sydney
School of Optometry and Vision Science, University of New South Wales, Sydney
Vision Eye Institute, Chatswood
Downie Laboratory, Department of Optometry and Vision Sciences, Melbourne
Eye Laser Specialists, Armadale
Waverley Eye Clinic, Glen Waverley
Deakin University, Waurn Ponds
Bendigo Eye Clinic, Bendigo
Ophthalmic Trials Australia, Teneriffe
Queensland University of Technology, Brisbane
Queensland Eye Institute, South Brisbane
Seema Eye Care, Calgary
FYI Doctors, Campbell River
Miller Optometry, Halifax
VCH Research Institute., Vancouver
Ophthalmology, Vancouver
Ocean Optometry, Halifax
Prism Eye Institute, Brampton
Cliantha Research, Mississauga
Precision Cornea Centre, Ottawa
Ottawa Hospital, Ottawa
FYI Doctors, Toronto
Healthpoint, Toronto
Eyes on Sheppard Clinic, Toronto
Toronto Eye Care, Toronto
Toronto Western Hospital, Toronto
School of Optometry & Vision Science, University of Waterloo, Waterloo
Lead Sponsor
Collaborators (2)
Syneos Health
OTHER
Cliantha Research
OTHER
Azura Ophthalmics
INDUSTRY